Related Experiment Video

Updated: May 22, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
06:54

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

Crosstalk between p53 and TGF-β Signalling

Rebecca Elston1, Gareth J Inman

  • 1Division of Cancer Research, Medical Research Institute, Ninewells Hospital and Medical School, University of Dundee, Dundee DD1 9SY, UK.

Journal of Signal Transduction
|May 1, 2012
PubMed

Insights

Wild-type p53 and transforming growth factor-beta (TGF-β) are crucial tumor suppressors. Mutant p53 can disrupt TGF-β signaling, promoting cancer progression by interfering with tumor-suppressive gene activation and miRNA biogenesis.

Area of Science:

  • Molecular Biology
  • Cancer Biology
  • Cellular Signaling

Background:

  • Wild-type p53 and transforming growth factor-beta (TGF-β) are critical tumor suppressors regulating cellular responses.
  • TGF-β exerts its effects partly through the Smad signal transduction pathway.
  • Interactions between p53 and Smads are vital for inducing tumor-suppressive genes.

Purpose of the Study:

  • To investigate the crosstalk between p53 and TGF-β signaling pathways.
  • To explore the implications of this crosstalk in cancer biology.
  • To understand how mutant p53 affects TGF-β responses and tumor progression.

Main Methods:

  • The study focuses on the molecular interactions between p53, TGF-β, and Smad proteins.
  • It examines the impact of these interactions on gene transcription and miRNA biogenesis.
  • Investigates the role of p53-Smad complexes in cancer development.

Main Results:

  • Mutant p53 subverts tumor-suppressive TGF-β responses, reducing the activation of key TGF-β target genes.
  • Mutant p53 can form complexes with Smads and p63, inhibiting metastasis-suppressing gene activation.
  • p53 and Smad pathways may overlap in miRNA biogenesis, influencing miRNA maturation.

Conclusions:

  • Crosstalk between p53 and TGF-β signaling significantly influences cancer biology.
  • Mutant p53 actively promotes tumor progression by disrupting normal cellular suppressive mechanisms.
  • Understanding these interactions offers potential therapeutic targets for cancer treatment.

More Related Videos

Visualization and Quantification of TGFβ/BMP/SMAD Signaling under Different Fluid Shear Stress Conditions using Proximity-Ligation-Assay11:38

Visualization and Quantification of TGFβ/BMP/SMAD Signaling under Different Fluid Shear Stress Conditions using Proximity-Ligation-Assay

Published on: September 14, 2021

Analysis of the c-KIT Ligand Promoter Using Chromatin Immunoprecipitation09:40

Analysis of the c-KIT Ligand Promoter Using Chromatin Immunoprecipitation

Published on: June 27, 2017

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.